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Background: Chronic urticaria (CU) is defined as the urticaria persisting for more 
than 6 weeks. However the etiology is frequently deemed as unclear, as most 
classical investigations failed to find the causes. Some patients with CU complain 
about aggravation of their symptoms after meal ingestion. However, it seems that 
clinically relevant allergies to food itself are thought to be rare (less than 10%) in 
patients with CU. Food additives are the substances artificially added in the food 
and a few of these are known to be implicated in allergic or allergy-like reactions. 
However, the role of food additives in CU is also still under investigation. Basophil 
activation test (BAT) is an in vitro diagnostic tool to identify the activation of 
basophil, and is now increasingly applied in various fields of allergic researches. 
We aimed to explore the association between food additives and CU using  BAT.  
Methods: The BAT was performed with 15 common food additives in 15 patients 
with CU who had histories of recurrent aggravation after various food intakes 
without definite food-specific IgE.  
Results: Among the 15 patients studied, only two patients (13.3%) presented 
positive BAT to the food additives. One patient responded to monosodium 
glutamate, showing 18.7% of CD203c basophil expression. Another patient showed 
a positive BAT to sodium benzoate. Both patients had clinical correlations with the 
agents, which were partly proven by elimination diets. 
Conclusion: The present study suggested a potential role of the BAT with food 
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Chronic urticaria (CU) is defined as the urticaria persisting for more than 6 weeks. 
However, the etiology is frequently deemed as unclear, as most classical 
investigations failed to find the causes (1). Although approximately one-half of CU 
cases have been shown to have an autoimmune etiology, the remaining cases have 
no known etiology or culprit agent despite thorough evaluation (1). The literature 
shows that 30% of patients believe that food might be a cause of their CU because 
variations in the diet, especially those that contain high levels of spices, seasonings, 
or natural histamine-like substances aggravated their symptoms (2, 3). However, 
clinically relevant allergies to foods are thought to be rare (occurring in less than 10% 
of cases) in patients with CU (4).  
Food additives are substances used as sweeteners, flavorings, coloring agents, 
antioxidants or preservatives (5). There are thousands of substances (6), while 
relatively few have been identified in the significant adverse reactions (7). Of these, 
tartrazine, benzoate, monosodium glutamate (MSG), sulfite, aspartame, nitrites, 
salicylate and some colorants have been tipped as the potential culprits for adverse 
food reactions (5). Their potential roles in CU pathogenesis have been suggested by 
a few studies (8-13), but they are still under investigation. The reasons for the lack 
of evidence could be attributed to the practical difficulty of performing the gold 
standard test, the double-blind placebo-controlled food challenge (DBPCFC) (14, 




such as inconsistent inclusion criteria and the absence of a standardized challenge 
protocol exist, and the outcome of the DBPCFC is not always satisfactory (11, 16, 
17). The skin prick test, which is widely used to screen sensitized allergens, is not 
useful for discriminating food additives hypersensitivity (13). Assuming the culprit 
additive depends solely on the patient’s subjective symptoms, which are sometimes 
vague and provoked by unrelated foods. Therefore, the selection of potential 
culprits among various kinds of food additives is also problematic.  
The flow cytometric basophil activation test (BAT) is an in vitro tool to assess the 
expression of basophil activation markers after antigen stimulation. The test has 
strengths in that it can detect not only IgE-mediated responses (18-20) but also non-
IgE-mediated immediate hypersensitivity (21-26), which means that it can be 
applied to allergic diseases of which the mechanism is not clearly known. Moreover, 
the BAT is not time consuming and able to examine multiple antigens at the same 
time. 
 
In this regard, we supposed that the BAT may have potential applications for the 
diagnosis of food additives hypersensitivity in CU patients. The present study aimed 









From October 2011 through March 2013, a total of 15 CU patients (duration >6 
weeks) from the division of allergy and clinical immunology of Seoul National 
University Bundang Hospital (SNUBH) were prospectively and consecutively 
enrolled in this study. They were included if they reported recurrent aggravations of 
urticaria by various kinds of food from history including food diary but did not have 
clear evidence of food-specific IgE by skin prick test or food-specific IgE 
measurements. Skin prick tests were performed for 55 kinds of common food 
allergens in Korea (Allergopharma, Reinbeck, Germany)(27), and food-specific IgE 
were measured by the RIDA Allergy Screen (R-biopharm, Darmastadt, Germany) 
or UniCAP system (Thermo Fischer, Uppsala, Sweden). In case of positive skin 
tests or specific IgE tests, clinical correlation was determined by allergy specialists. 
All patients voluntarily participated in this study, and provided written informed 








(Buhlmann, Schonenbuch, Switzerland) according to the manufacturer’s instruction. 
A total of 15 food additives, which had been previously reported to cause 
hypersensitivity reactions, were tested using commercial allergens of the CAST®-
Allergens (Buhlmann, Schonenbuch, Switzerland), which included MSG, sodium 
nitrite, tartrazine, sodium salicylate, potassium metabisulfite, sodium benzoate, and 
food colorant mixⅠ(quinolone yellow, sunset yellow FCF, chromotrope FB, 
amaranth and new coccine), and food colorant mix Ⅱ(erythrosine, patent blue V, 
indigo carmine, and brilliant black BN)(28).  
 
Briefly, the BAT was performed using the following steps. The patients’ blood was 
processed within 2 hours after sampling in EDTA tubes. After removing the 
erythrocytes, the sample was treated with stimulation buffer solution. The cell 
suspensions were divided into 11 tubes containing two positive controls, one 
negative control, and the 15 kinds of food additives described above, respectively. 
For the positive controls, monoclonal antibodies to high affinity IgE receptors and 
nonspecific N-formyl-methionyl-leucyl-phenylalanine (fMLP) were used. The 
stimulation buffer was added to the tubes for background and negative control. The 
results of the BAT were expressed as percentages of basophils expressing CD203c 
which was known to be increasingly expressed on the basophil surface after 
allergenic stimulation in sensitized individuals and was regarded as a basophil 
activation marker. The expression of CD203c was detected with anti-CD203c-





Stimulation index (SI) = percentage of basophils activated by the food additive / 
percentage of activated basophils in the negative control.  
 
The BAT was determined to be positive if the basophil activation was ≥ 5% and the 





Characteristics of Study Subjects 
A total of 15 patients with CU were enrolled in this study (Table 1). They had a 
mean age of 38.7 ± 13.2 years, and 80.0% of them were women. The mean duration 
of symptoms was 33.0 ± 17.7 months. Only one patients (6.3%) showed elevated 
peripheral eosinophil counts and 7 patients (46.6%) had elevated total IgE levels ≥ 
250 IU/mL. None had anti-thyroid hormone antibodies. Five patients (33.3%) were 
positive in skin testing or UniCAP to the food allergens, but all of them did not 
show any clinical correlations with urticaria. 
 
Table 1. Baseline characteristics of 15 chronic urticaria patients 
 
Total (n=15) 
   Age, year 38.7 ± 13.2 
   Sex, M:F 3:12  
   Asthma 3 (20.0%) 
   Allergic rhinitis 5 (33.3%) 
   Drug hypersensitivity 5 (33.3%) 
   Whole blood cell counts 7817.9 ± 2751.5 
   Peripheral eosinophil counts 119.2 ± 143.6 
   Total IgE (IU/mL) 319.8 ± 316.4 
   Positive skin prick test to food allergens†    4/11 (36.4%) 
   Positive specific IgE to food allergens‡ 1/8 (12.5%) 




†The skin prick test was performed with a standardized technique using 55 kinds of 
commercially available extracts of a food allergen panel (Allergopharma, Reinbeck, 
Germany) as well as histamine and saline as a positive and negative control, 
respectively. 
‡Food-specific IgE was measured by using the RIDA Allergy Screen (R-biopharm, 
Darmastadt, Germany) or UniCAP (Thermo Fischer, Uppsala, Sweden). 
 
The results of the BAT, skin test and specific IgE test in each patient are 
summarized in Table 2. Two patients (13.3%) showed positive BAT to any of food 
additives. The detailed histories of these cases are described as follows. 
 
Case 1. 
A 37-year-old woman visited the outpatient allergy clinic because of urticaria. She 
suffered from recurrent generalized urticaria, rash, and facial angioedema. She 
complained that the urticarial aggravation occurred particularly when eating high-
seasoned, spicy, or Chinese foods. Previously, she had been treated for allergic 
rhinitis and also had experienced severe urticaria with a generalized rash after 
taking non-steroidal anti-inflammatory drugs (NSAIDs). Peripheral eosinophil 
counts and serum total IgE in her blood were 97.2/μL and 97 kU/L, respectively. T4 
and thyroid stimulating hormone were also within normal range. A skin prick test 
showed weakly positive reactions (wheal size ≥ 3mm but allergen/histamine ratio < 




provoked urticaria in the history. In the BAT, a total of 18.7% of basophils were 
activated after stimulation with MSG (Figure 1); however, the other 14 additives did 
not induce significant basophil activation, compared to the negative control (1.3%). 
 
 
Figure 1. Basophil activation test results for patient 1 showing monosodium 
glutamate (MSG) hypersensitivity. (a) The basophils were identified as SSClow 
CCR3high from the gated lymphocytes, (b) As a negative control, background 
basophil activation with stimulation buffer only (1.3%), (c) As a positive control, 
basophil activation with anti-IgE antibody (71.4%), (d) The percentage of activated 
basophils stimulated with MSG was 18.7%. The stimulation index (SI) with MSG 
was 15.0. 
 
Case 2.  
A 19 year-old female high school student with recurrent urticaria visited the allergy 
clinic. She complained of recurrent episodes of localized urticaria and erythematous 
rashes on face. She had been experiencing urticarial symptoms that had developed 
after eating a school meal. Her past medical history or family history was 




eosinophil count and serum total IgE were within the normal range. The result of an 
autologous serum skin test was also negative. There were no food allergens which 
positively reacted to the skin prick test. In BAT, only sodium benzoate activated 
basophils significantly (37.5% activation; Figure 2). After she abstained from the 
food additives by avoiding the relevant processed foods, her urticarial symptoms 
were resolved dramatically without further anti-histamine medications.  
 
 
Figure 2. Basophil activation test results for patient 2 showing sodium benzoate 
hypersensitivity. (a) The basophils were identified as SSClow CCR3high from the 
gated lymphocytes, (b) As a negative control, background basophil activation with 
stimulation buffer only (3.1%), (c) As a positive control, basophil activation with 
anti-IgE antibody (8.3%), (d) The percentage of activated basophils treated with 































































































































































































































































































































































































































































































































































































































































































































































































The present study explored the proportion of patient with food additives 
hypersensitivity in 15 CU patients via the utilization of the BAT. All of them had 
recurrent urticaria aggravated by various food intakes, which did not have evident 
food-specific IgE against common food allergens. A total of 13.3% of participants 
showed a positive BAT to any of the tested 15 common food additives, which may 
suggest a potential clinical utility of the BAT in such cases.  
 
 
CU can be provoked by specific physical factors, such as pressure, heat, cold, 
sunlight and even non-specific stimuli (1). However, for most of the patients with 
CU, it did not have a well-described cause. Recent advances in the pathogenesis of 
CU revealed that 45% of patients presented autoimmune markers such as anti-
FcεRI-α, anti-IgE or thyroid autoantibodies, and an autologous serum skin test was 
positive in 4.1-76.5% of cases (29). However, the etiology of the remaining 55% of 
patients is still unknown and remained ‘idiopathic’. 
 
Many patients regard that urticaria are attributed to food allergies because their 
symptoms seem to fluctuate according to their diet. There are several reports that 
22.5-30.0% of patients regard food as the cause of CU (2, 3). However, contrary to 
these patients’ beliefs, it seems that only less than 10% of CU might be associated 
with IgE mediated food allergies (30). Kobra and his colleagues examined the 
results of DBPCFC and only 10% of patients who complained about food-provoked 




The clinical features of CU that can be associated with diet could be somewhat 
different from those of food allergies. Food allergy is mediated by an IgE-dependent 
allergic mechanism and is more likely to result in acute urticaria as a generalized 
allergic reaction. Food allergy also develops in response to only certain foods and/or 
some foods or vegetables that share antigenic similarity (32). However, in CU, 
similar cutaneous reactions could be developed by several apparently unrelated 
foods and is especially more common as a reaction to commercially prepared forms 
of foods that are tolerated when prepared at home (33). These distinct clinical 
features in CU could arise from food additives, and not from the food itself. 
 
About 3,968 substances are registered in Everything Added to Food in the United 
States which is regularly updated by the U.S Food and Drug Administration (6). 
Despite the great number of food additives, only a few have been implicated in 
adverse reactions and are mainly mediated through non-IgE mediated immunologic 
or non-immunologic mechanisms (5). There have been several case reports on 
urticaria, angioedema, asthmatic reactions and anaphylaxis caused by food additives 
(8-13, 16, 17). In some of these studies, they performed the oral provocation test for 
food additives and revealed that hypersensitivity to food additives is the cause of 
CU. However, some of these studies have limitations (5, 8, 9, 33, 34). The challenge 
procedure was executed under poorly controlled circumstances, which were not 
double-blinded or placebo-controlled. There have been large-scale studies on the 
prevalence of food additives hypersensitivity in the general population and it has 
been reported to be quite low (less than 1%, usually 0.18~0.2%) (35-37). However, 




additives (36). However, these studies also had limitations due to the fact that the 
criteria for patient selection and study design were not consistent. 
 
The DBPCFC is the gold standard to diagnose hypersensitivity to foods or food 
additives (32). However, it is difficult to execute this on patients with CU in actual 
clinical practice. Patients with CU are usually taking an antihistamine, which should 
be discontinued for a certain period. However this may cause an increase in the 
activity of CU, and thus cause a false positive reaction to the provocation. On the 
contrary, if the antihistamine is not sufficiently stopped, a false negative result can 
occur even though food additives are the cause of CU. It is also difficult to conduct 
the test in a placebo-controlled manner due to the fact that food additives have their 
own taste and smell. Additionally, in many cases, it is difficult to select candidate 
additives solely based on the patients’ symptoms and food diaries. 
 
A pseudoallergen-free diet can be an alternative option to determine the possibility 
of hypersensitivity to food additives as a cause of CU. Previous studies reported that 
a pseudoallergen-free diet could be effective to reduce the severity of CU (10, 16, 
38-40). Margel et al. tested a pseudoallergen-free diet on 140 CU patients, and 34% 
showed significant improvement on urticarial severity and/or quality of life (40). 
However, a pseudoallergen-free diet restricts all preserved and processed food, and 
even all spices and herbs, eggs, cakes, biscuits, tomatoes, fresh and dried fruits, 
except for salt and chives. Therefore, it is hard to carry out in real life and might 





There are many attempts to develop in vitro methods to diagnose the cause of CU. 
Recently, basophils are gaining much attention due to their important roles in CU 
(41-44). Basophils play an important role in traditional IgE-mediated food allergies 
(45). Due to the biological response in which activated basophils plays an important 
role in causing an allergic reaction, it would be more suitable to measure basophil 
responsiveness after antigenic stimulation rather than to measure the level of 
specific IgE in order to evaluate the clinical reactivity of CU. The BAT measures 
the level of expression of CD63 or CD203c on basophil surfaces with flow 
cytometry after stimulation of blood cells with allergen (19, 20, 46). CD63 or 
CD203c, which is used as a basophil activation marker, exists within the secretory 
vesicles inside the basophil at resting stage, and when the basophil is activated 
causing secretion of the vesicles, the CD63 or CD203c moves to the surface of cell 
membrane. The level of degranulation of mediators as a result of basophil activation 
is known to be directly proportional with the expression CD63 and/or CD203c (47-
49).  
 
There are numerous reports on the usefulness of the BAT in various allergic 
diseases. It proved to be especially useful in diagnosing bee or wasp venom 
anaphylaxis (50). The BAT could be used to test the induction of tolerance in 
children with cow’s milk allergy (51). The BAT is also effective in diagnosing food 
allergies such as IgE-mediated reactions against pollen-derived food (19, 20) or 
wheat (46). It is also useful to test non-allergic or pseudoallergic reactions including 
drugs (26) such as muscle relaxants (22), antibiotics (23), NSAIDs(24), and  even 




However, the BAT for food additives has not been sufficiently studied yet. Garcia-
Ortega and his colleagues confirmed using the BAT that hypersensitivity to sodium 
metabisulfite induced CU (52). Ebo et al. reported the case of a patient who had a 
history of recurrent anaphylaxis after eating cheese, and found that hypersensitivity 
to the natural dye annatto (Ceska Annato WS E160b), which was positive on the 
BAT, was the cause of anaphylaxis (53). In our study, the BAT was performed on 
CU patients whose symptoms were suspected to be related to hypersensitivity to 
food additives. The culprit was not clearly identified through their history, food 
diaries, skin prick tests for common food allergens or other additional laboratory 
tests. Of these patients, one patient showed a positive BAT to MSG and another to 
sodium benzoate. In these two patients, no symptom developed when they ate at 
home, but the conditions deteriorated when they ate outside the home, especially for 
Chinese foods or soups with plenty of seasonings and spices. 
 
The present study has several limitations. First, we did not perform the DBPCFC for 
the two positive cases as the patients did not agree to perform the oral provocation 
tests with each additive. Instead, we instructed them on how to restrict the specific 
additives in their daily diet. Eventually, their symptoms improved after starting a 
specific food additive-free diet. Second, our low percentage of participants with the 
positive food additives BAT (13.3%) could raise questions on its diagnostic utility. 
Several factors are presumed to be responsible. We tested only 15 kinds of common 
food additives, which could be insufficient for screening purposes. Another 
possibility could be due to false negative results of the BAT, as shown in our 




have influenced the positivity of BAT, and have limited our interpretation on the 
diagnostic utility. We suppose that the positivity might be increased if the subjects 
were more specifically selected for food additives reactions with oral provocation 
tests. Nevertheless, our two positive cases were clinically meaningful, as they could 
have remained unresolved without the diagnostic investigations. Third, we only 
performed the BAT for 15 patients with CU. This small sample size limits the 
interpretation of our results. Due to the quite low prevalence of food additives 
hypersensitivity and it’s as-yet undetermined role, a large-scale study is needed to 
further evaluate the potential utility of BAT with food additives. 
 
Despite the issues surrounding the use of the BAT for food additives, it could be a 
good alternative to the oral provocation test as a means to evaluate hypersensitivity 
to food additives in patients with CU. First, it can be applied not only in IgE-
mediated, but also in non-IgE mediated reactions, which means that it can be 
applied to allergic diseases for which the underlying mechanism is not clearly. In 
addition, BAT results are not affected by anti-histamine or steroid use. Therefore it 
can prevent the exacerbation of urticaria stemming from the discontinuance of such 
drugs as well as false negative results for oral provocation tests due to insufficient 
discontinuation of drugs. The BAT can be used to evaluate multiple candidate 
allergens or materials simultaneously and independently. It is not easy to identify 




a screening tool for hypersensitivity to various additives could prevent the need to 





The pathogenesis of CU has not been clearly determined, and various 
environmental factors are suspected to be involved. In our explorative study, two of 
the 15 (13.3%) participants showed positive results in a BAT using food additives. 
Although these positive results may appear to be low, they were clinically 
meaningful as the conditions of these two patients could have remained as 
‘idiopathic’ or ‘unexplained’ without the identification of the possible causes by the 
BAT. It warrants further studies evaluating the diagnostic utility of the BAT for 
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서론: 만성두드러기는 6 주 이상 반복적으로 두드러기가 발생하는 질환으로, 
발생기전과 유발요인을 규명하기 위한 연구가 활발하게 진행되었으나 아직까지 
명확하게 밝혀지지 않았다. 만성두드러기 환자의 일부에서 음식물과의 연관성이 
의심되나, 실제로 식품알레르기가 진단되는 경우는 드문 것으로 알려져 있다. 
식품 첨가물은 다양한 목적으로 음식물에 첨가되는 물질로, 일부에서 알레르기 
또는 알레르기양 반응을 유발할 수 있는 것으로 알려져 있다. 하지만 아직까지 
식품 첨가물에 대한 과민반응이 실제로 만성두드러기를 유발하는 원인인지에 
대해서는 충분히 연구되지 않았다. 호염기구 활성시험은 항원 자극 후 
호염기구의 활성 정도를 측정하는 생체외 실험기법으로, 최근 다양한 알레르기 
질환의 진단 및 평가에 사용되고 있다. 본 논문에서는 음식물 연관성을 보이는 
만성두드러기 환자에게 식품 첨가물에 대한 호염기구 활성시험을 통해 
만성두드러기와 식품첨가물의 관련성을 알아보고자 하였다. 
방법: 식품알레르기는 배제되었지만 음식물 연관성이 의심되는 만성두드러기 
환자 15 명을 대상으로, 15 개의 흔한 식품첨가물에 대한 호염기구 
활성시험(basophil activation test)을 시행하였다.  
결과: 15 명의 만성두드러기 환자들 중 2 명이 식품첨가물에 대한 호염기구 
활성시험에서 양성소견을 보였다. 한 명은 글루탐산모노나트륨(monosodium 
glutamate) 처리 후 호염기구 활성지표인 CD203c 를 발현한 호염기구가 
18.7%로 증가했고, 자극지수(stimulation index)는 15.0 이었다. 다른 환자는 
벤조산나트륨(sodium benzoate)에 양성 반응을 보였고, 37.5%의 호염기구가 




활성시험에서 양성으로 나왔던 첨가물 제한 식이 (elimination diet) 후 
만성두드러기가 유의하게 호전되었다.  
결론: 식품첨가물에 대한 호염기구 활성시험은 음식 연관성을 보이는 
만성두드러기 환자에서 식품 첨가물에 대한 과민반응을 진단하는데 도움이 될 
수 있을 것이다.  
주요어: 만성두드러기, 식품 첨가물, 과민반응, 알레르기, 호염기구 활성시험, 
글루탐산모노나트륨, 벤조산나트륨 
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